-+ 0.00%
-+ 0.00%
-+ 0.00%

OMEROS CORPORATION - PLANS CLINICAL STUDIES IN ARDS AND HIGH-RISK TA-TMA IN PEDIATRIC PATIENTS LATER THIS YEAR

Reuters·10/16/2026 10:22:11